Thereby, the suppression of AKT, inhibition of NF-κB, upregulation of JNK activity and subsequent reduction of Bcl-2 and Bcl-xl expression might contribute to the increased sensitivity of NSCLC cells to APG and TRAIL-mediated apoptosis (Fig. 9). The gene discussed is BCL2; the disease is non-small cell lung carcinoma.